Long-term outcomes after switching from baricitinib 4 mg to upadacitinib 30 mg in atopic dermatitis: a 144-week retrospective study
收藏Mendeley Data2026-05-21 收录
官方服务：
资源简介：
Supplementary Methods Supplementary Table 1 Supplementary Table 2
创建时间：
2026-05-08
